Evidence map›Paper›PMID 26974334›Full record

ArticlePloS one2016

Generation of Mice with Hepatocyte-Specific Conditional Deletion of Notum.

Frédéric Canal, Sara Charawi, Gisèle Grimber, Christophe Houbron, Valérie Drouet, Sabine Colnot, Benoit Terris, Catherine Cavard, Christine Perret

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Notum Deletion From Late-Stage Skeletal Cells Increases Cortical Bone Formation and Potentiates Skeletal Effects of Sclerostin Inhibition.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2021
    Article
  3. Structural Insights into Notum Covalent Inhibition.Journal of medicinal chemistry · 2021
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Osteoblast-derived NOTUM reduces cortical bone mass in mice and theFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Frédéric CanalInserm, U1016, Institut Cochin, 75014 Paris, France.
Sara CharawiInserm, U1016, Institut Cochin, 75014 Paris, France.
Gisèle GrimberInserm, U1016, Institut Cochin, 75014 Paris, France.
Christophe HoubronInserm, U1016, Institut Cochin, 75014 Paris, France.
Valérie DrouetInserm, U1016, Institut Cochin, 75014 Paris, France.
Sabine ColnotInserm, U1016, Institut Cochin, 75014 Paris, France.
Benoit TerrisInserm, U1016, Institut Cochin, 75014 Paris, France.
Catherine CavardInserm, U1016, Institut Cochin, 75014 Paris, France.
Christine PerretInserm, U1016, Institut Cochin, 75014 Paris, France.
Centre National de la Recherche Scientifique · FRInserm · FRDélégation Paris 5 · FRInstitut Cochin · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFine tuning of the Wnt/β-catenin signaling pathway is essential for the proper development and function of the liver. Aberrant activation of this pathway is observed in 20%-40% of hepatocellular carcinomas (HCC). Notum encodes a secreted Wnt deacylase that inhibits Wnt activity and thereby restricts the zone of activation of Wnt/β-catenin signaling. An important role of NOTUM has been described in development in drosophila, planaria and zebrafish, but its role in the mammalian liver is unknown. Notum is required for spatial control of the Wnt/β-catenin signaling in several animal models and the Wnt/β-catenin pathway contributes to liver patterning involved in metabolic zonation. Therefore, Notum may be involved in the liver patterning induced by the Wnt/β-catenin signaling during the adult stage. METHODOLOGY/PRINCIPAL

findingsWe generated a conditional Notum knockout mouse mutant to study the effect of the deletion of Notum in the liver. We show that Notum is a direct target of the Wnt/β-catenin signaling in the liver. Liver-specific deletion of Notum did not modify liver zonation, but Notum deletion had a long-term effect on mouse physiology. In particular, male mutant mice developed metabolic disorders.

conclusionWe show that Notum is not a key actor of Wnt/β-catenin-dependent liver patterning of adult mice, but has role in liver glucose homeostasis. Male mice deficient in Notum specifically in the liver develop metabolic dysfunctions implicating Notum in the development of Type 2 diabetes.

Indexed as

Diabetes Mellitus, Type 2Gene DeletionAnimalsEsterasesFemaleHepatocytesLiverMaleMiceMice, Mutant StrainsOrgan SpecificityWnt Signaling PathwayEsterases

Identifiers

PMID26974334
PMCPMC4790944
OpenAlexW2297898110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.